General American Investors Co. Inc. Has $15,873,000 Position in CVS Health Corporation (CVS)
General American Investors Co. Inc. maintained its position in CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 197,280 shares of the pharmacy operator’s stock at the close of the 2nd quarter. General American Investors Co. Inc.’s holdings in CVS Health Corporation were worth $15,873,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors also recently added to or reduced their stakes in the company. Mercer Capital Advisers Inc. acquired a new position in shares of CVS Health Corporation during the 1st quarter worth $118,000. Gemmer Asset Management LLC raised its holdings in shares of CVS Health Corporation by 15.3% during the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after buying an additional 200 shares in the last quarter. TB Alternative Assets Ltd. acquired a new position in shares of CVS Health Corporation during the 2nd quarter worth $121,000. SRS Capital Advisors Inc. raised its holdings in shares of CVS Health Corporation by 48.2% during the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after buying an additional 734 shares in the last quarter. Finally, Grace & White Inc. NY acquired a new position in shares of CVS Health Corporation during the 2nd quarter worth $199,000. Hedge funds and other institutional investors own 81.51% of the company’s stock.
Shares of CVS Health Corporation (CVS) opened at 72.60 on Friday. The firm has a 50 day moving average price of $79.16 and a 200-day moving average price of $78.87. The company has a market cap of $73.80 billion, a price-to-earnings ratio of 14.46 and a beta of 0.92. CVS Health Corporation has a 52-week low of $69.30 and a 52-week high of $88.84.
CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings data on Tuesday, August 8th. The pharmacy operator reported $1.33 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.31 by $0.02. The business had revenue of $45.69 billion for the quarter, compared to analysts’ expectations of $45.36 billion. CVS Health Corporation had a return on equity of 17.47% and a net margin of 2.93%. The business’s revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the firm posted $1.32 EPS. Equities research analysts anticipate that CVS Health Corporation will post $5.88 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th will be given a dividend of $0.50 per share. The ex-dividend date of this dividend is Monday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.75%. CVS Health Corporation’s payout ratio is 39.92%.
In other CVS Health Corporation news, CFO David M. Denton sold 237,078 shares of CVS Health Corporation stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $79.65, for a total transaction of $18,883,262.70. Following the sale, the chief financial officer now directly owns 141,096 shares of the company’s stock, valued at approximately $11,238,296.40. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Larry J. Merlo sold 241,150 shares of CVS Health Corporation stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $83.07, for a total value of $20,032,330.50. Following the sale, the insider now directly owns 299,255 shares in the company, valued at $24,859,112.85. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 716,625 shares of company stock worth $58,318,431. Insiders own 0.61% of the company’s stock.
A number of equities analysts have recently commented on CVS shares. Leerink Swann set a $90.00 price target on CVS Health Corporation and gave the stock a “buy” rating in a report on Tuesday, June 27th. Needham & Company LLC started coverage on CVS Health Corporation in a report on Tuesday, June 27th. They set a “hold” rating for the company. Guggenheim reissued a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 3rd. Jefferies Group LLC reissued a “hold” rating and set a $82.00 price target on shares of CVS Health Corporation in a report on Friday, July 14th. Finally, BidaskClub cut CVS Health Corporation from a “hold” rating to a “sell” rating in a report on Monday, July 24th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and sixteen have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $90.23.
CVS Health Corporation Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.